IP Library Granted Patent US 8,476,044
Granted Patent B2
US 8,476,044 · App. 12/148,133 · Granted Jul 2, 2013

Method of nucleic acid amplification

Inventors: Pascal Mayer (Geneva, CH); Laurent Farinelli (Vevey, CH); Eric H. Kawashima (Geneva, CH)
Assignee: Illumina, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,476,044
App. No.
12/148,133
Granted
Jul 2, 2013
Kind
B2
Abstract

A nucleic acid molecule can be annealed to an appropriate immobilized primer. The primer can then be extended and the molecule and the primer can be separated from one another. The extended primer can then be annealed to another immobilized primer and the other primer can be extended. Both extended primers can then be separated from one another and can be used to provided further extended primers. The process can be repeated to provide amplified, immobilized nucleic acid molecules. These can be used for many different purposes, including sequencing, screening, diagnosis, in situ nucleic acid synthesis, monitoring gene expression, nucleic acid fingerprinting, etc.

Claims (15)

1. A method of simultaneously sequencing a population of random nucleic acid molecules of unknown sequence, comprising:

(a) attaching known ends to said population of random nucleic acids thereby forming a plurality of nucleic acid targets each of said nucleic acid targets comprising a first part having a sequence capable of annealing to a first amplification primer, a second part having a sequence complementary to a sequence capable of annealing to a second amplification primer, and a third part comprising a random unknown sequence located between the first and second parts, wherein the known ends are attached to each of the random nucleic acids in the population;

(b) dispersing the plurality of nucleic acid targets such that individual target molecules of the plurality of nucleic acid targets are separated from each other; and

(c) performing an amplification reaction using first and second amplification primers, wherein the first amplification primer anneals to the first part of each of said nucleic acid targets, the second amplification primer anneals to a sequence complementary to the second part of each of said nucleic acid targets and wherein at least said first or said second amplification primers are immobilized at different locations on a single solid support, such that each of the plurality of nucleic acid targets is simultaneously amplified thereby producing 1000 or more different nucleic acid colonies of immobilized amplified nucleic acid molecules, a plurality of said immobilized amplified nucleic molecules in each of said colonies having the same sequence, and wherein the amplification reaction results in amplification of each of the random nucleic acids in the population; and

(d) simultaneously sequencing the immobilized amplified nucleic acid molecules present in said 1000 or more different nucleic acid colonies such that said population of random nucleic acid molecules of unknown sequence are simultaneously sequenced.

2. The method according to claim 1 , wherein said sequencing comprises the steps of:

(d1) hybridizing primers to the immobilized amplified nucleic acid molecules;

(d2) extending the primers by addition of one or more labeled nucleotides, thereby producing incorporated labeled nucleotides; and

(d3) detecting said incorporated labeled nucleotides.

3. The method according to claim 2 , wherein steps (d2) and (d3) are repeated one or more times.

4. The method according to claim 3 , wherein a label attached to the one or more labeled nucleotides is removed after step (d3).

5. The method according to claim 2 , wherein unincorporated nucleotides from said one or more labeled nucleotides are removed after step (d2).

6. The method according to claim 2 , wherein step (d3) uses a charge-coupled-device camera coupled to a magnifying device.

7. The method according to claim 1 , wherein the solid support comprises a planar solid support.

8. The method according to claim 7 , wherein said 1,000 or more different nucleic acid colonies are 1,000,000 or more different nucleic acid colonies.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2014
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 032868/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2014
From: KAWASHIMA, ERIC H.; FARINELLI, LAURENT; MAYER, PASCAL
To: GLAXO GROUP LIMITED
Reel/Frame 032874/0519 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: SMITHKLINE BEECHAM CORPORATION
To: MANTEIA SA
Reel/Frame 032864/0123 →
CHANGE OF NAME Recorded May 9, 2014
From: LYNX THERAPEUTICS INC.
To: SOLEXA, INC.
Reel/Frame 032864/0753 →
MERGER Recorded Feb 9, 2011
From: SOLEXA, INC.
To: ILLUMINA, INC.
Reel/Frame 025777/0639 →
CHANGE OF NAME Recorded May 12, 2009
From: LYNX THERAPEUTICS, INC.
To: SOLEXA, INC.
Reel/Frame 022676/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2009
From: MANTEIA S.A.
To: SOLEXA, LTD.; LYNX THERAPEUTICS, INC.
Reel/Frame 022680/0940 →
CHANGE OF NAME Recorded Dec 12, 2008
From: SOLEXA LIMITED
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 021983/0444 →
Priority Claims (4)
GB 9706528.8 · Apr 1, 1997 · national
GB 9706529.6 · Apr 1, 1997 · national
GB 9713236.9 · Jun 23, 1997 · national
GB 9713238.5 · Jun 23, 1997 · national
Continuity (3)
Division 10449010 · Jun 2, 2003
Continuation 09402277
Related Publication 20080286795A1 · Nov 20, 2008